Laura Graciotti

Dr. Laura Graciotti

Dipartimento di Scienze Biomediche e Sanità Pubblica, Facolta di Medicina e Chirurgia, Università Politecnica delle Marche, Via Tronto, 10, 60126 Torrette di Ancona, Italy
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2012 in AGE
Verified
Journal Article
Closed access
PDF file
FOFabiola Olivieri
Fabiola Olivieri
RLRaffaella Lazzarini
Raffaella Lazzarini
RRRina Recchioni
Rina Recchioni
FMFiorella Marcheselli
Fiorella Marcheselli
Maria RippoMaria Rippo
Maria Rippo
APAntonio Domenico Procopio
Antonio Domenico Procopio

18 February 2020 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
EMEmanuela Mensà
Emanuela Mensà
Michele GuesciniMichele Guescini
Michele Guescini
AGAngelica Giuliani
Angelica Giuliani
MBMaria Giulia Bacalini
Maria Giulia Bacalini
DRDeborah Ramini
Deborah Ramini
FOFabiola Olivieri
Fabiola Olivieri
The role of epigenetics in endothelial cell senescence is a cutting‐edge topic in ageing research. However, little is known of the relative contribution to pro‐senescence signal propagation provided by microRNAs shuttled by extracellular vesicles (EVs) released from senescent cells. Analysis of microRNA and DNA methylation profiles in non‐senescent (control) and senescent (SEN) human umbilical vein endothelial cells (HUVECs), and microRNA profiling of their cognate small EVs (sEVs) and large EVs demonstrated that SEN cells released a significantly greater sEV number than control cells. sEVs were enriched in miR‐21‐5p and miR‐217, which target DNMT1 and SIRT1. Treatment of control cells with SEN sEVs induced a miR‐21/miR‐217‐related impairment of DNMT1‐SIRT1 expression, the reduction of proliferation markers, the acquisition of a senescent phenotype and a partial demethylation of the locus encoding for miR‐21. MicroRNA profiling of sEVs from plasma of healthy subjects aged 40–100 years showed an inverse U‐shaped age‐related trend for miR‐21‐5p, consistent with senescence‐associated biomarker profiles. Our findings suggest that miR‐21‐5p/miR‐217 carried by SEN sEVs spread pro‐senescence signals, affecting DNA methylation and cell replication.

19 March 2013 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
FOFabiola Olivieri
Fabiola Olivieri
Maria RippoMaria Rippo
Maria Rippo
FPFrancesco Prattichizzo
Francesco Prattichizzo
LBLucia Babini
Lucia Babini
Laura GraciottiLaura Graciotti
Laura Graciotti
APAntonio Domenico Procopio
Antonio Domenico Procopio
The age-related changes of immune system functions are complex phenomena incompletely understood. The acquired immune system shows a functional decline in ability to respond to new pathogens during aging, whereas serum levels of inflammatory cytokines are increased with age. The source of this age-related systemic chronic inflammation, named inflammaging, was mainly attributed to the progressive activation of immune cells over time. However, recent studies have shown that the process of cellular senescence can be an important additional contributor to chronic inflammation, since senescent cells acquire a phenotype named “senescence-associated secretory phenotype” (SASP), characterized by the enhanced secretion of many inflammation modulators. Pathogen-associated molecular pattern receptors, in particular Toll-like receptors (TLRs), are key molecules in the response of innate immunity cells to pathological stimuli. An intriguing and innovative hypothesis is that the dysfunction of TLRs signaling and the acquisition of SASP can be two interconnected phenomena. The TLR family, including receptors and co-effector molecules, do not show a consistent age-dependent change across model systems. However, there is evidence for impaired downstream signaling events, including inhibition of positive and activation of negative modulators of TLR signaling. MicroRNAs (miRNAs) are a newly discovered class of gene regulators acting as post-transcriptional repressors of a number of genes. The miRNA property to finely-tune gene expression makes them right for immune system regulation, which requires precise control for proper activity. We reviewed evidences suggesting that miRNAs can modulate TLR signaling mainly by three different mechanisms: 1) miRNAs can directly target components of the TLR signaling system, 2) miRNA expression can be directly regulated by TLRs pathway activation and 3) miRNAs can directly activate the RNA-sensing TLRs, like TLR-8, in humans. We also reviewed how TLR signaling is modulated by miRNAs during aging, and how an impaired miRNAs/TLR signaling interaction in immune system cells and related cells, i.e. endothelial cells and adipocytes, can contribute to inflammaging observed in normal aging. Interestingly, this impairment appears accelerated in presence of the majors age-related diseases, such as cardiovascular diseases, diabetes, neurodegenerative diseases and cancers.

1 October 2013 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
FOFabiola Olivieri
Fabiola Olivieri
RLRaffaella Lazzarini
Raffaella Lazzarini
LBLucia Babini
Lucia Babini
FPFrancesco Prattichizzo
Francesco Prattichizzo
MRMaria Rita Rippo
Maria Rita Rippo
APAntonio Domenico Procopio
Antonio Domenico Procopio

1 March 1996 in Microvascular Research
Verified
Journal Article
Closed access
Stuart EggintonStuart Egginton
Stuart Egginton
OHO. Hudlicka
O. Hudlicka
MBM D Brown
M D Brown
Laura GraciottiLaura Graciotti
Laura Graciotti
AGA.L. Granata
A.L. Granata

20 December 2016 in Aging Cell
Verified
Journal Article
Open access
PDF file
MCMiriam Capri
Miriam Capri
FOFabiola Olivieri
Fabiola Olivieri
CLCatia Lanzarini
Catia Lanzarini
Daniel RemondiniDaniel Remondini
Daniel Remondini
VBVincenzo Borelli
Vincenzo Borelli
Gian Luca GraziGian Luca Grazi
Gian Luca Grazi
To understand why livers from aged donors are successfully used for transplants, we looked for markers of liver aging in 71 biopsies from donors aged 12–92 years before transplants and in 11 biopsies after transplants with high donor–recipient age-mismatch. We also assessed liver function in 36 age-mismatched recipients. The major findings were the following: (i) miR-31-5p, miR-141-3p, and miR-200c-3p increased with age, as assessed by microRNAs (miRs) and mRNA transcript profiling in 12 biopsies and results were validated by RT–qPCR in a total of 58 biopsies; (ii) telomere length measured by qPCR in 45 samples showed a significant age-dependent shortage; (iii) a bioinformatic approach combining transcriptome and miRs data identified putative miRs targets, the most informative being GLT1, a glutamate transporter expressed in hepatocytes. GLT1 was demonstrated by luciferase assay to be a target of miR-31-5p and miR-200c-3p, and both its mRNA (RT–qPCR) and protein (immunohistochemistry) significantly decreased with age in liver biopsies and in hepatic centrilobular zone, respectively; (iv) miR-31-5p, miR-141-3p and miR-200c-3p expression was significantly affected by recipient age (older environment) as assessed in eleven cases of donor–recipient extreme age-mismatch; (v) the analysis of recipients plasma by N-glycans profiling, capable of assessing liver functions and biological age, showed that liver function recovered after transplants, independently of age-mismatch, and recipients apparently ‘rejuvenated’ according to their glycomic age. In conclusion, we identified new markers of aging in human liver, their relevance in donor–recipient age-mismatches in transplantation, and offered positive evidence for the use of organs from old donors.